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ABSTRACT 
Objective: The goal was to investigate the antibacterial activity of the extracts of Euphobia hirta and Pysalis angulata from Ghana on clinical 
bacteria isolate found to associate with wound and skin infections. 
Methods: The aqueous and crude ethanolic extracts and extract-PEG ointment formulation as well as the combination of the extracts of P. angulata 
and E. hirta were tested against Psedomonas aeruginosa and Staphylococcus. aureus, using the agar diffusion bioassay. Antibacterial activities were 
indicated by the diameters of zones of inhibition of bacterial growth for both the test extracts as well the extract-PEG ointment formulations.  
Results: Ethanolic crude extract of E. hirta inhibited P. aeruginosa at inhibition zones ranging from 24±0.08 mm at 50 µg/ml to 21.00±0.40 mm at 
250 µg/ml, whilst the aqueous crude extracts showed potency against P. aeruginosa at varying inhibition zones ranging from 20±0.60 mm at 250 
µg/ml to 4.00±0.20 mm at 50 µg/ml. Ethanolic E. hirta crude extracts exhibited potency against S. aureus and was dose dependent, with a decrease 
in inhibition as concentration increased, recording a minimum zone of inhibition at 13.00±0.30 mm at 250 µg/ml and maximum zone of inhibition 
of 16.00±0.20 mm at 50 µg/ml. Only one concentration of 100 µg/ml at 20±0.60 mm zone for the aqueous extract of E. hirta was potent against S. 
aureus. Ethanolic crude extract of P. angulata inhibited P. aeruginosa at zones ranging from 23±0.30 mm at 100 µg/ml to 13.00±0.20 mm at 50 
µg/ml, whereas the aqueous crude extracts showed potency against P. aeruginosa at dose dependent concentrations ranging from 10±0.30 mm at 
50 µg/ml to 13.00±0.30 mm at 250 µg/ml. Here, inhibition zone increased as concentration was increased. Ethanolic P. angulata crude extracts 
exhibited potency against S. aureus, recording a minimum zone of inhibition at 12.00±0.40 mm at 50 µg/ml and maximum zone of inhibition of 
21.00±0.30 mm at 250 µg/ml. At lower concentration of 50 µg/ml, the combination of ethanolic E. hirta and P. angulata inhibited S. aureus at a zone 
of inhibition of 2 mm for the combination of the crude aqueous extracts; P. aeruginosa was inhibited at the zone of 1.0 mm with extract 
concentration of 50 µg/ml. A one-way analysis of variance (ANOVA) of the above values compared with the activity of Ciprofloxacin (positive 
control) indicated significant inhibitory activity by the unformulated P angulata and E hirta ethanolic crude extracts.  
Conclusion: The study indicates that crude extracts of E. hirta and P. angulate are possible sources of natural antibacterial agents against both skin 
and wound infections caused by S. aureus and P. aeruginosa. 
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INTRODUCTION 
Communicable diseases are key sources of indisposition and 
mortality in the developing world and accounts for about 50 % of all 
demises. Bacterial resistance to antibiotics upsurges mortality, 
possibility of hospitalization and the dimension of stay in the 
hospital [1]. The spread of resistance, which is transportable 
amongst members of the enterobacteriaceae, has been ascribed to 
the conscription of drug resistance markers by a diversity of agents 
encoded on plasmids, transposon and integrons [2]. Isolation of 
bacteria less susceptible to regular antibiotics and recovery of 
resistant isolates during antibacterial therapy is now a global 
problem [3]. In the developing world, the condition is equally worst 
because of poor sanitation and illiteracy of decent hygienic practices 
thus divulging an enormous number of people to infectious agents. 
Some of the bacteria implicated in causing enteric infections include 
but not limited to E. coli, salmonella spp. Proteus spp., shigella spp., 
pseudomonas spp. and the staphylococci [4]. 
These bacteria which are habitually existent as commensal have 
numerous virulent factors and colonize in a biofilm fashion, causing 
a variety of intestinal and extraintestinal diseases [5]. The success 
story of modern medicine lies in the incessant quest for novel drugs 
to counter the challenges posed by resistant strains of bacteria. 
There is, therefore, the necessity to develop some newer, safer, 
effective and above all, inexpensive antimicrobial agents to wrestle 
this problem. There are numerous reports in the scientific literature 
recounting the antimicrobial properties of crude extracts prepared 
from plants [6] and such reports had enticed the attention of 
scientists worldwide. 
The importance of medical ethnobotanic research has been 
increasing since potential sources for drugs could disappear in the 
future as a result of the rapid loss of biodiversity 
Many plant extracts have been used as herbal medicines for the 
treatment of many diseases. Extracts are administered as syrup as 
well as in the form of essential oils and creams. These extracts have 
been used from times immemorial as phytoremedy, traditionally all 
over the world. E. hirta is a medicinal, rhizomatous herb, which in 
East and West Africa extracts of the plant are used in the treatment of 
asthma and respiratory tract inflammations. It is also used for coughs, 
chronic bronchitis and other pulmonary disorders [7]. It is reported 
that extracts or exudates of the plant are used as ear drops and in the 
treatment of boils, sore and promotion of wound healing [8].  
Research indicates that E. hirta is known to be very popular herb 
amongst practitioners of traditional medicine, widely used as a 
decoction or infusion to treat various ailments including intestinal 
parasites, diarrhoea, peptic ulcers, heartburn, vomiting, amoebic 
dysentery, asthma, bronchitis, hay fever, laryngeal spasms, 
emphysema, coughs, colds, kidney stones, menstrual problems, 
sterility and venereal diseases [9]. Additionally, the plant is similarly 
used to treat infections of the skin and mucous membranes, 
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including warts, scabies, tinea, thrush, aphthae, fungal afflictions, 
measles, guinea-worm and as an antiseptic to treat wounds, sores and 
conjunctivitis [9]. The plant has a status as an analgesic to treat a severe 
headache, toothache, rheumatism, colic and pain during pregnancy. 
Other reports indicate its use as an antidote and pain reliever of scorpion 
stings and snakebites [9]. The use of the latex to expedite removal of 
thorns from the skin is also common. In Ghana, a number of plant-based 
products are claimed to be effective for the treatment of onchocerciasis 
[10]. Extracts from the plant of E. hirta have been found to have the 
potential to serve as anticancer agents [10]. 
The plant, P. angulata is an annual herb distributed in many 
countries located in tropical and subtropical regions of the world. 
The plant is extensively used in popular medicine as a treatment for 
an assortment of diseases and has antitumoral activity already 
demonstrated [11, 12]. P. angulata has a broad spectrum of 
biological activity including antibacterial, molluscicidal, antiprotozoal, 
anticancer and cytotoxic and immunomodulatory activities [13, 14]. In 
Ghana, it is called “totototo” among the Akans. The juice is used in the 
treatment of an earache, jaundice, fever, bladder disease and the fruit 
and other aerial parts are used in the treatment of boils, sores or 
wounds, constipation and digestive problems [15, 16].  
The pathogen, S. aureus is a gram-positive bacterium and perhaps 
the most dangerous of all the many common staphylococcal bacteria 
[17]. The spread of these bacteria is by direct contact with an 
infected person, by using a contaminated object, or by inhaling 
infected droplets dispersed by sneezing or coughing. Skin infections 
are common, but the bacteria can spread through the bloodstream and 
infect distant organs. Skin infections may cause blisters, abscesses, 
redness and swelling in the infected area. Antibiotics are chosen based 
on whether they are likely to be effective against the strain causing the 
infection. People most likely to be carriers include those whose skin 
are repeatedly punctured or broken, such as individuals with diabetes 
mellitus and have to regularly inject insulin, those who inject illegal 
drugs, ones being treated with hemodialysis or chronic ambulatory 
peritoneal dialysis, individuals with skin infections, AIDS, or previous 
staphylococcal bloodstream infections [17]. 
There are many strains of S. aureus and some produce toxins that 
can cause the symptoms of staphylococcal food poisoning, toxic 
shock syndrome and scalded skin syndrome. Many strains have 
developed resistance to the effects of antibiotics, and if carriers take 
antibiotics, the antibiotics kill the strains that are not resistant, 
leaving mainly the resistant strains. These bacteria may then multiply, 
and if they cause infection, the infection is more difficult to treat. 
Whether the bacteria are resistant and which antibiotics they resist 
often depend on where people got the infection: in a hospital or other 
health care facility or outside of such a facility. Staphylococcal 
infections may be difficult to treat because many of the bacteria have 
developed resistance to antibiotics [17], hence, the need for 
alternative therapeutics which necessitated the relevance of this 
research. P. aeruginosa is also a gram-negative rod-shaped bacterium. 
These pathogens are widespread in nature, inhabiting soil, water, 
plants, and animals including humans. They are notorious in causing 
nosocomial infections such as pneumonia, urinary tract infections, 
respiratory system infections and infections of severe burns [18].  
MATERIALS AND METHODS 
Source of test bacteria 
Clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa 
were collected from incision type wounds at the Kintampo Health 
Research Centre in the Brong Ahafo Region of Ghana, in June 2014. 
The isolates were sub-cultured to verify purity on chocolate agar 
(OXOID, Basingstoke, Hampshire, England) and stored between 2ºC 
and 8ºC in nutrient broth (OXOID, Basingstoke, Hampshire, England). 
Plant material 
Aerial parts (leaves, stems, and flowers) of the E. hirta plant and 
leaves of P. angulate were collected from Tono irrigation farms in 
Navrongo in the Upper East Region of Ghana in October 2013. The 
plant material was authenticated by Dr. Isaac Sackey of the 
Department of Applied Biology in the Faculty of Applied Sciences, 
University for Development Studies, Navrongo Campus 
Sample preparation 
The plant samples were air-dried at room temperature of (25-30 o
Preparation of ethanol extracts of the plants sample 
C) 
for two weeks, after which they were ground into a uniform powder. 
Powdered plants samples, 60 g each of E. hirta and P. angulata were 
measured into round bottom flasks and both flooded with 95 % 
ethanol. The flasks were stoppered and left to stand for 24 h. The 
extracts were then filtered using sterilized cotton wool. The filtrates 
were concentrated under reduced pressure using rotary evaporator. 
The resultant materials were kept in sample vials and stored in a 
refrigerator for further analysis. 
Aqueous extracts of the plants sample 
Powdered samples, 60 g each was measured into beakers, and the 
volumes made up to 600 mL with distilled water; enough to cover 
the mixture. The mixtures were stirred for 10 min after which the 
plant materials were filtered through sterilized cotton wool. The 
filtrates were concentrated using rotary evaporator. The residues 
were then stored in the refrigerator for use in the next experiment. 
Preparation of polyethylene glycol (PEG) ointment 
A mass of 15 g each of Polyethylene glycol 4000 (PEG 4000) and 
Polyethylene glycol 400 (PEG 400) was weighed into a beaker and 
melted on a thermostatic water bath at 70 ℃ until liquefied to make 
50 % PEG 4000 and 50 % PEG 400. It was stirred with a glass rod 
under tap water at room temperature until congealed. [19] 
Combination of extracts of Euphorbia hirta and Physalis angulate  
Equal amount of each of the concentrations (50, 100, 200 and 250) 
µg/ml of E. hirta were amalgamated with equal amount of each of 
the concentration of P. angulata to produce a mixture of crude 
extract of E. hirta and P. angulata at concentrations 50 µg/ml, 100 
µg/ml, 200 µg/ml and 250 µg/ml. The mixtures were then vortexed 
for two minutes and used to test for antibacterial activities. The 
same process was used to test for the combination of the aqueous 
extracts of the two plants. 
Plant crude extract-PEG ointment formulations 
Employing a previous method of [19], E. hirta and P. angulate crude 
extracts were separately formulated together with PEG ointment to 
determine whether they would have a potential effect on the 
bacterial isolates. Equal quantities (25, 50, 100, and 200 µg) of each 
crude extract were weighed into appropriately labeled separate 
beakers; E. H1–E. H4 for E. hirta and P. A1–P. A4 for P. angulata PEG 
ointment. The extract-PEG, 1.0 g, was then added to each beaker and 
warmed at 40 ℃ while stirring continuously with a glass rod. The 
mixtures were allowed to cool at room temperature (25-30 o
Agar diffusion bioassay 
C) to 
produce a crude extract-PEG ointment formulation at varying 
concentrations of 25 µg/mg, 50 µg/mg, 100 µg/mg and 200 µg/mg 
respectively of each plant extract. The combination of the two plants 
was also formulated to test for their synergistic effect.  
The modified agar well diffusion method was employed. Colonies of 
a pure culture of each test organism was suspended in 100 ml of 
sterile peptone water to get a turbidity of about 1 McFarland 
Standard. Aliquots of 0.1 ml of each suspension were separately 
surface-plated on different Mueller Hinton Agar (OXOID) plates. 
Wells of 5 mm diameters were made on the culture plates with a 
sterile cork borer at wide enough intervals. For each sample, 100 µl 
was drawn into a labeled well. The same volumes of the negative 
control (98% DMSO) and positive control (Ciprofloxacin at 30 µg/µl) 
were also introduced into a well each on the same plate. Plates were 
left to stand until complete diffusion of the formulations into the 
medium. Plates were incubated in inverted positions at 37 °C for 48 
h after which they were observed for inhibitory activity depicted by 
zones of inhibition around the wells. Inhibition zone diameters were 
measured using a ruler and recorded in millimetres (mm). The 
experiments were repeated three times to check for reproducibility. 
The same procedure was used to test for the antibacterial activity of 
crude extract-ointment formulation. 
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Means and standard error of the mean were calculated for the zones 
of inhibition measured for the three sets of experiments in each case. 
These means were statistically compared using the one–way ANOVA 
to determine if they were significantly different at P<0.05. 
RESULTS 
The antibacterial activity of crude and formulated extracts of P. 
angulate and E. hirta were studied at concentrations of 25 µg/ml, 50 
µg/ml, 100 µg/ml and 200 µg/ml for both crude extracts and of 25 
µg/mg, 50 µg/mg, 100 µg/mg and 200 µg/mg for the PEG ointment 
formulations. The test bacteria used were P. aeruginosa and S. 
aureus which are commonly associated with skin and wounds 
infections. The results showed the concentration-dependent 
inhibitory activity of the extracts against the test bacteria. Largely, 
most of the crude extracts showed increasing levels of inhibition at 
variable concentrations. Antibacterial activities were indicated by 
the diameters of zones of inhibition of bacterial growth for both the 
test extracts as well the extract-PEG ointment formulations.  
Aqueous crude extract of E. hirta was potent against P. aeruginosa 
which was dose dependent with a maximum zone of inhibition of 
20±0.06 mm at a concentration of 250 µg/ml. The crude ethanolic 
extract exhibited an opposite trend, with maximum zone found to be 
24±0.08 mm at a concentration of 50 µg/ml (fig 1). Both the 
ethanolic and aqueous extract-PEG formulation did not exhibit a 
substantial level of potency against P. aeruginosa and S. aureus in 
this current work (Data not shown). Previous work conducted by 
[19], formulation of cleome viscosa crude extract-PEG ointment 
showed appreciable zones of inhibition against P. aeruginosa. In that 
work the extract-PEG formulation was warmed to 40 o
 
C to liquefy 
before applying to the test organism.  
 
Fig. 1: Representative antibacterial activity of unformulated 
aqueous and crude ethanolic extracts of Euphobia hirta against 
P. aeruginosa 
(■) E. hirta aqueous crude extracts (μg/ml), (■) E. hirta 
ethanolic crude extracts (μg/ml), (■) Standard antibiotic 
(Ciprofloxacin) (µg/g) 
 
In the current work, the procedure was modified for the purpose of 
differentiating the effect of the two different processes. Here, the 
extract-PEG ointment formulation was applied to the test organism 
directly without liquefying. The comparison of the two separate 
experiments indicates that liquefying the extract-PEG ointment 
formulation seems to achieve better results due to the fact that the 
active drug stands a better chance of getting in contact with the test 
bacteria compared with just the direct application of the semi-solid 
ointment formulation to the test organism. This has been confirmed in 
our laboratory by a recent unpublished data collected on another 
formulation studies. In this study, E. hirta showed activity against S. 
aureus with maximum inhibition at 50 µg/ml for the ethanolic extracts 
and only concentration of 100 µg/ml showed inhibition against S. 
aureus with the aqueous extracts (fig. 2). 
The current research indicates that crude aqueous extract of P. 
angulata inhibited P. aeruginosa in a dose-dependent fashion with a 
maximum zone of 13.00±0.03 at a concentration of 250 µg/ml. The 
crude ethanolic extract showed a linear correlation between the zones of 
inhibition and the concentrations used, with increased zones with 
respect to increased concentration of the extracts up to 200 µg/ml but 
showed a deviation at 250 µg/ml with a reduction in inhibition zone (fig. 
3). Further, both the ethanolic and aqueous extract-PEG formulation of P. 
angulate did not significantly inhibit both bacteria, which might be 
attributable to the reasons suggested above. 
 
 
Fig. 2: Representative antibacterial activity of unformulated 
aqueous and ethanolic extracts of E. hirta against S. aereus 
(■) E. hirta aqueous crude extracts (μg/ml); (■) E. hirta 




Fig. 3: Representative antibacterial activity of unformulated 
aqueous and ethanolic extracts of P. angulata against P. aeruginosa 
(■) P. angulata crude aqueous extracts (μg/ml);(■) P. angulata 
ethanolic crude extracts (μg/ml); (■) Standard antibiotic 
(Ciprofloxacin) (µg/g) 
 
The crude ethanolic extracts were potent against S. aereus with 
maximum zone occurring at 21.00±0.30 at a concentration of 250 
µg/ml whilst the aqueous extracts showed no inhibition at all 
concentrations used in this research (fig. 4).  
 
 
Fig. 4: Representative antibacterial activity of unformulated 
aqueous and ethanolic extracts of P. angulata against S. aereus 
(■) P. angulata crude aqueous extracts (μg/ml); (■) P. angulate 
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At low concentration of 50 µg/ml, the combination of ethanolic E. 
hirta and P. angulata inhibited S. aureus at a zone of inhibition of 2 
mm (fig. 5). For aqueous combination, P. aeruginosa was inhibited 
with a zone of inhibition of 1 mm at a concentration of 50 µg/ml (fig. 
not shown). However, the formulation prepared by the combination 
of the crude extract-PEG formulations of both E. hirta and P. 
angulata used in this research did not show an appreciable level of 
potency against the bacteria at all concentrations employed. 
 
 
Fig. 5: Representative antibacterial activity of amalgamated 
aqueous and ethanolic extracts of E. hirta and P. angulata 
against S. aereus 
(■) Combination of E. hirta and P. angulata crude ethanolic 
extracts (μg/ml), (■) Standard antibiotic (Ciprofloxacin) (µg/g) 
 
DISCUSSION 
In the present study, ethanolic extract of both E. hirta and P. 
angulata exhibited inhibitory activity against S. aureus and P. 
aeruginosa supporting their ethno pharmacological utilization of the 
medicinal species against wound and skin infections in Ghanaian 
communities. The level of potency observed against these two 
bacteria by E. hirta and P. angulata ethanolic extracts further 
validate the use of these plants in Ghanaian ethnotherapy. For the 
ethanolic extracts of the medicinal plant E. hirta against P. 
aeruginosa and S. aureus, inhibition was found to decrease as the 
concentration of the extracts decreased, whilst the ethanolic extracts 
of P. angulata against both bacteria demonstrated an inconsistent 
pattern of inhibition (fig. 6). 
 
 
Fig. 6: Representative antibacterial activity of ethanolic extracts 
of E. hirta and P. angulata against P. aeruginosa and S. aureus 
(■) E. hirta crude ethanolic extracts against P. aeruginosa; (■) E. 
hirta ethanolic crude extracts against S. aereus; (■) P. angulata 
ethanolic extracts against P. aeruginosa (■)P. angulata 
ethanolic extracts against S. aureus 
 
A research report by Donkor et al. [20], indicated that anti-
plasmodial activities of crude ethanolic extracts of Moringa oleifera 
presented similar trend as exhibited by the ethanolic extract of E. 
hirta in this current research. The observed biological activity calls 
upon further investigation to isolate the active phytochemicals 
responsible for the reported activity. The aqueous extracts of both 
plants showed a similar trend in activity against P. aeruginosa that 
is, increased activity with increasing concentration of extracts. It can 
be pointed out that, E. hirta crude extract was much more significant 
in terms of potency compared with that of P. angulata which gave a 
lower level of potency against the bacteria (fig. 7). Again, the 
synergistic experiments of both the ethanolic and aqueous extracts 
could not exhibit significant inhibition on both bacterial species  
 
 
Fig. 7: Representative antibacterial activity of aqueous extracts 
of E. hirta and P. angulata against P. aeruginosa and S. aureus 
(■) E. hirta aqueous crude extracts against P. aeruginosa; (■) E. 
hirta aqueous crude extracts against S. aereus; (■) P. angulata 
aqueous extracts against P. aeruginosa (■)P. angulata aqueous 
extracts against S. aureus 
 
CONCLUSION 
The study indicates that crude extracts of E. hirta and P. angulate are 
possible sources of natural antibacterial agents to be used against 
both skin and wound infections. The potency of Ciprofloxacin could 
be matched by the isolated bioactive compound(s) from the plants 
parts used. Largely, the extracts showed antibacterial action against 
both S. aureus and P. aeruginosa. These results have link with claims 
made by traditional practitioners for control of skin and wound 
infections and among the reasons traditional knowledge is 
considered reliable for the exploitation of herbal remedies. Future 
study on separation and purification of the bioactive compounds will 
contribute medicinally to application of these plants worldwide. 
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